<?xml version="1.0" encoding="UTF-8"?>
<ref id="B27">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jafari</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Molavi</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Kahroba</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Hejazi</surname>
    <given-names>M. S.</given-names>
   </name>
   <name>
    <surname>Maleki-Dizaji</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Barghi</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2020</year>). 
  <article-title>Clinical application of immune checkpoints in targeted immunotherapy of prostate cancer.</article-title>
  <source>
   <italic>Cell. Mol. Life Sci.</italic>
  </source>
  <volume>77</volume>
  <fpage>3693</fpage>â€“
  <lpage>3710</lpage>. 
  <pub-id pub-id-type="doi">10.1007/s00018-020-03459-1</pub-id>
  <?supplied-pmid 32006051?>
  <pub-id pub-id-type="pmid">32006051</pub-id>
 </mixed-citation>
</ref>
